Literature DB >> 8639890

Overexpression of HOXB4 enhances the hematopoietic potential of embryonic stem cells differentiated in vitro.

C D Helgason1, G Sauvageau, H J Lawrence, C Largman, R K Humphries.   

Abstract

Little is known about the molecular mechanisms controlling primitive hematopoietic stem cells, especially during embryogenesis. Homeobox genes encode a family of transcription factors that have gained increasing attention as master regulators of developmental processes and recently have been implicated in the differentiation and proliferation of hematopoietic cells. Several Hox homeobox genes are now known to be differentially expressed in various subpopulations of human hematopoietic cells and one such gene, HOXB4, has recently been shown to positively determine the proliferative potential of primitive murine bone marrow cells, including cells with long-term repopulating ability. To determine if this gene might influence hematopoiesis at the earliest stages of development, embryonic stem (ES) cells were genetically modified by retroviral gene transfer to overexpress HOXB4 and the effect on their in vitro differentiation was examined. HOXB4 overexpression significantly increased the number of progenitors of mixed erythroid/myeloid colonies and definitive, but not primitive, erythroid colonies derived from embryoid bodies (EBs) at various stages after induction of differentiation. There appeared to be no significant effect on the generation of granulocytic or monocytic progenitors, nor on the efficiency of EB formation or growth rate. Analysis of mRNA from EBs derived from HOXB4-transduced ES cells on different days of primary differentiation showed a significant increase in adult beta-globin expression, with no detectable effect on GATA-1 or embryonic globin (beta H-1). Thus, HOXB4 enhances the erythropoietic, and possibly more primitive, hematopoietic differentiative potential of ES cells. These results provide new evidence implicating Hox genes in the control of very early stages in the development of the hematopoietic system and highlight the utility of the ES model for gaining insights into the molecular genetic regulation of differentiation and proliferation events.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8639890

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  26 in total

1.  HoxB5 is an upstream transcriptional switch for differentiation of the vascular endothelium from precursor cells.

Authors:  Yaxu Wu; Martin Moser; Victoria L Bautch; Cam Patterson
Journal:  Mol Cell Biol       Date:  2003-08       Impact factor: 4.272

2.  Analysis of HSC activity and compensatory Hox gene expression profile in Hoxb cluster mutant fetal liver cells.

Authors:  Janet Bijl; Alexander Thompson; Ramiro Ramirez-Solis; Jana Krosl; David G Grier; H Jeffrey Lawrence; Guy Sauvageau
Journal:  Blood       Date:  2005-12-08       Impact factor: 22.113

3.  Hematopoiesis and immunity of HOXB4-transduced embryonic stem cell-derived hematopoietic progenitor cells.

Authors:  Kun-Ming Chan; Sabrina Bonde; Hannes Klump; Nicholas Zavazava
Journal:  Blood       Date:  2007-12-04       Impact factor: 22.113

4.  Generation of mesenchymal stromal cells from HOXB4-expressing human embryonic stem cells.

Authors:  Yi-Ping Liu; Peiman Hematti
Journal:  Cytotherapy       Date:  2009       Impact factor: 5.414

Review 5.  Making HSCs in vitro: don't forget the hemogenic endothelium.

Authors:  Bradley W Blaser; Leonard I Zon
Journal:  Blood       Date:  2018-08-08       Impact factor: 22.113

6.  Effect of increased HoxB4 on human megakaryocytic development.

Authors:  Yiming Zhong; Brent Sullenbarger; Larry C Lasky
Journal:  Biochem Biophys Res Commun       Date:  2010-06-22       Impact factor: 3.575

7.  HOXB4 Increases Runx1 Expression to Promote the de novo Formation of Multipotent Hematopoietic Cells.

Authors:  Nadine Teichweyde; Peter A Horn; Hannes Klump
Journal:  Transfus Med Hemother       Date:  2017-05-19       Impact factor: 3.747

Review 8.  Designer blood: creating hematopoietic lineages from embryonic stem cells.

Authors:  Abby L Olsen; David L Stachura; Mitchell J Weiss
Journal:  Blood       Date:  2005-10-27       Impact factor: 22.113

9.  Targeted disruption of SHIP leads to hemopoietic perturbations, lung pathology, and a shortened life span.

Authors:  C D Helgason; J E Damen; P Rosten; R Grewal; P Sorensen; S M Chappel; A Borowski; F Jirik; G Krystal; R K Humphries
Journal:  Genes Dev       Date:  1998-06-01       Impact factor: 11.361

10.  Bcl2 enhances induced hematopoietic differentiation of murine embryonic stem cells.

Authors:  Yan-Yi Wang; Xingming Deng; Lijun Xu; Fengqin Gao; Tammy Flagg; W Stratford May
Journal:  Exp Hematol       Date:  2007-11-26       Impact factor: 3.084

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.